专题：Bladder and Urothelial Cancer Treatments

This cluster of papers focuses on the diagnosis, treatment, and management of bladder cancer, particularly urothelial carcinoma. It covers topics such as chemotherapy, cystectomy, neoadjuvant therapy, molecular characterization, metastatic bladder cancer, guidelines for management, and immunotherapy. The papers provide insights into various aspects of bladder cancer research and clinical practice.
最新文献
Racial and Ethnic Disparities in the Utilization of Partial Nephrectomy and Robotic Surgery for Renal Cell Carcinoma

article Full Text OpenAlex

Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer

article Full Text OpenAlex

Age-related changes in the urinary microbiome of healthy Japanese children

article Full Text OpenAlex

Long-term renal outcomes after pediatric pyeloplasty: Defining optimal imaging intervals and predictors of functional recovery

article Full Text OpenAlex

ctDNA-guided immunotherapy following radical cystectomy for muscle-invasive bladder cancer: results from the TOMBOLA trial

article Full Text OpenAlex

Integrative bulk and single-cell transcriptomic analysis reveals COL1A2-driven ECM remodeling and focal adhesion signaling associated with the transition from non-muscle-invasive to muscle-invasive bladder cancer

article Full Text OpenAlex

Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non–muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials

article Full Text OpenAlex

Is there still a role for ureteric frozen section analysis during radical cystectomy?

article Full Text OpenAlex

Long-term sexual outcomes in classic bladder exstrophy: Insights from standardized scores

article Full Text OpenAlex

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

article Full Text OpenAlex

近5年高被引文献
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

article Full Text OpenAlex 793 FWCI464.9277

The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours

review Full Text OpenAlex 762 FWCI107.3044

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines

review Full Text OpenAlex 576 FWCI167.0514

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update

review Full Text OpenAlex 480 FWCI156.1077

Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors

review Full Text OpenAlex 431 FWCI138.6295

Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma

article Full Text OpenAlex 430 FWCI138.4048

Bladder cancer

review Full Text OpenAlex 407 FWCI131.6455

Current best practice for bladder cancer: a narrative review of diagnostics and treatments

review Full Text OpenAlex 405 FWCI85.2332

Advances in diagnosis and treatment of bladder cancer

article Full Text OpenAlex 381 FWCI223.3534

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

article Full Text OpenAlex 327 FWCI46.0697